Notably, in an important study, Cunningham and Myhre (47) argued that NT-proBNP is an imperfect surrogate to assess the response to HF therapies because a convincing sensitivity analysis, which exclusively included patients with an ejection fraction of less than 30%, revealed no relationship between treatment effects and NT-proBNP concentrations. Here, NPPB is linked to hydrops fetalis.